Y-Intercept (HK)’s Tandem Diabetes Care TNDM Stock Holding History

Y-Intercept (HK)’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.75M	Buy	314,653 +236,774	+304%	+$4.13M	0.09%	296
2026 Q1	$1.49M	Sell	77,879 -6,107	-7%	-$133K	0.03%	857
2025 Q4	$1.85M	Buy	83,986 +27,061	+48%	+$488K	0.04%	662
2025 Q3	$691K	Buy	+56,925	New	+$771K	0.02%	1141
2025 Q1	–	Sell	-14,147	Closed	-$510K	–	1609
2024 Q4	$510K	Buy	+14,147	New	+$479K	0.03%	715
2024 Q2	–	Sell	-25,028	Closed	-$886K	–	1924
2024 Q1	$886K	Buy	25,028 +3,661	+17%	+$98.1K	0.07%	438
2023 Q4	$632K	Buy	+21,367	New	+$443K	0.06%	485
2023 Q3	–	Sell	-14,265	Closed	-$350K	–	1597
2023 Q2	$350K	Buy	+14,265	New	+$459K	0.04%	707
2022 Q3	–	Sell	-8,116	Closed	-$480K	–	1270
2022 Q2	$480K	Buy	+8,116	New	+$666K	0.06%	442

Other funds holding TNDM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Y-Intercept (HK)'s TNDM Position: Q2 2026 in Review

Y-Intercept (HK) increased its Tandem Diabetes Care (TNDM) stake by 304% in Q2 2026, buying an estimated $4.13M and bringing the position to 314,653 shares worth $4.75M. The position accounts for 0.09% of the portfolio, ranked #296.

Y-Intercept (HK) first reported a position in TNDM in Q2 2022 and has held it in 9 quarters since. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

Y-Intercept (HK) held 314,653 shares of Tandem Diabetes Care worth $4.75M as of Q2 2026.
Y-Intercept (HK) bought 236,774 Tandem Diabetes Care shares in Q2 2026, an estimated $4.13M.
Tandem Diabetes Care made up 0.09% of Y-Intercept (HK)'s portfolio in Q2 2026, its #296 holding.
Y-Intercept (HK) first reported a position in Tandem Diabetes Care in Q2 2022 and has held it in 9 quarters since.
274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.